Alchemab

Alchemab discovers protective antibodies by profiling B cells from resilient patients to treat cancer, Alzheimer’s, and neurodegenerative diseases.
Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Series A
Initial Investment Year
2021
Alchemab Portco Hover Image